"This promising drug candidate was identified through an intensively cross-disciplinary, cross-continental combination of computer-based drug screening, medicinal chemistry, intuition and extensive preclinical testing," study co-senior author and 2012 Nobel laureate Brian Kobilka, Professor at the Stanford University School of Medicine, said.